Provided by Tiger Trade Technology Pte. Ltd.

Insmed

127.28
-1.5200-1.18%
Post-market: 128.401.12+0.88%17:52 EDT
Volume:2.59M
Turnover:330.12M
Market Cap:27.80B
PE:-31.13
High:128.85
Open:127.22
Low:124.29
Close:128.80
52wk High:212.75
52wk Low:90.39
Shares:218.38M
Float Shares:216.82M
Volume Ratio:1.28
T/O Rate:1.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.0882
EPS(LYR):-6.4200
ROE:-87.22%
ROA:-22.17%
PB:36.69
PE(LYR):-19.83

Loading ...

Insmed Files Form 3 for SVP, GM Global Respiratory Samuele Butera

Reuters
·
Jun 25

Insmed Chief Legal Officer Michael Alexander Smith Sells 1,806 Shares for $173,023.92

Reuters
·
Jun 25

Jefferies Reaffirms Their Buy Rating on Insmed (INSM)

TIPRANKS
·
Jun 23

Insmed names Samuele Butera SVP, GM of global respiratory unit

Reuters
·
Jun 23

Press Release: Insmed Appoints Samuele Butera as Senior Vice President, General Manager, Global Respiratory

Dow Jones
·
Jun 23

Insmed Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Jun 23

U.S. RESEARCH ROUNDUP-CAMP4 Therapeutics, Rockwell Automation, Zions Bancorporation

Reuters
·
Jun 16

Insmed (INSM) Stock Valuation After Pullback And Rare Disease Pipeline Debate

Simply Wall St.
·
Jun 16

Mizuho cuts Insmed target, sees buying opportunity after selloff

TIPRANKS
·
Jun 15

Mizuho Securities Adjusts Price Target on Insmed to $192 From $202, Maintains Outperform Rating

MT Newswires Live
·
Jun 15

Insmed’s New TPIP Liver Study Marks a Small but Important De‑Risking Step

TIPRANKS
·
Jun 12

Movement Alert|Insmed Rises 5.95% in Regular Trading, PAH Inhalation Therapy Phase 3 Trial Shows Positive Progress

Market Focus
·
Jun 12

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-06-11

Reuters
·
Jun 11

U.S. RESEARCH ROUNDUP-Arthur J. Gallagher & Co, Datadog, Oracle

Reuters
·
Jun 11

Insmed Inc : Guggenheim Cuts Target Price to $207 From $226

THOMSON REUTERS
·
Jun 11

Insmed Advances Phase 3 Inhaled PAH Therapy, Keeping Growth Hopes Alive

TIPRANKS
·
Jun 11

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2026-06-09

Reuters
·
Jun 10

Insmed Is Maintained at Overweight by JP Morgan

Dow Jones
·
Jun 08

Insmed stock price decline a ‘buying opportunity’, says Roth Capital

TIPRANKS
·
Jun 08

Insmed Inc : JP Morgan Cuts Target Price to $179 From $180

THOMSON REUTERS
·
Jun 08